Ground Swell Capital’s AbbVie ABBV Stock Holding History

Ground Swell Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,493	Closed	-$200K	–	79
2022 Q3	$200K	Buy	+1,493	New	+$214K	0.57%	63
2022 Q2	–	Sell	-1,724	Closed	-$279K	–	141
2022 Q1	$279K	Buy	+1,724	New	+$250K	0.72%	19
2021 Q3	–	Sell	-1,917	Closed	-$216K	–	67
2021 Q2	$216K	Buy	+1,917	New	+$216K	1.03%	38
2014 Q3	$171K	Buy	2,954 +1,176	+66%	+$65.3K	0.32%	48
2014 Q2	$100K	Buy	+1,778	New	+$93.3K	0.19%	56

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ground Swell Capital's ABBV Position: Q4 2022 in Review

Ground Swell Capital sold out of AbbVie (ABBV) in Q4 2022, closing a stake of 1,493 shares — an estimated $200K sold.

Ground Swell Capital first reported a position in ABBV in Q2 2014 and held it in 5 quarters. The position peaked at $279K in Q1 2022. 3,171 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

Ground Swell Capital reported no remaining AbbVie position as of Q4 2022 after selling out during the quarter.
Ground Swell Capital sold 1,493 AbbVie shares in Q4 2022, an estimated $200K.
Ground Swell Capital first reported a position in AbbVie in Q2 2014 and held it in 5 quarters.
Ground Swell Capital's AbbVie position peaked at $279K in Q1 2022.
3,171 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Ground Swell Capital's 13F filing for Q4 2022, filed 14 Feb 2023.